- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Tildrakizumab – July 2018
Tildrakizumab: Injection 100 mg in 1 mL single use pre-filled syringes; Ilumya®
Last updated
26 October 2018